Zhongli Cai

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

High Fat Diet Induced

Breast Cancer Cells

Gold Nanoparticles

Epidermal Growth Factor Receptor

Top Venues

Molecular pharmaceutics

International journal of radiation biology

This page only lists publications with an associated author ORCID identifier.

Publications

Valerie J Facca, Zhongli Cai, Anthony Ku, Constantine J Georgiou, Raymond M Reilly
Adjuvant Auger Electron-Emitting Radioimmunotherapy with [ 111 In]In-DOTA-Panitumumab in a Mouse Model of Local Recurrence and Metastatic Progression of Human Triple-Negative Breast Cancer. Molecular pharmaceutics (2023)
Zhongli Cai, Rella Liu, Conrad Chan, Yijie Lu, Mitchell A Winnik, David W Cescon, Raymond M Reilly
90 Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated Tumor. Molecular pharmaceutics 19 (11) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics 20 (1) (2022)
Constantine J Georgiou, Zhongli Cai, Noor Alsaden, Hyungjun Cho, Minou Behboudi, Mitchell A Winnik, James T Rutka, Raymond M Reilly
Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177 Lu. Molecular pharmaceutics (2022)
Valerie J Facca, Zhongli Cai, Nakita E K Gopal, Raymond M Reilly
Panitumumab-DOTA- 111 In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner-Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer. Molecular pharmaceutics 19 (10) (2022)
Simmyung Yook, Zhongli Cai, Jenny Jooyoung Jeong, Yijie Lu, Mitchell A Winnik, Jean-Philippe Pignol, Raymond M Reilly
Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with 177Lu Is More Potent for Killing Human Breast Cancer Cells That Coexpress HER2 and EGFR Than Single-Receptor-Targeted (SRT) Radiation Nanomedicines. Molecular pharmaceutics 17 (4) (2020)
Zhongli Cai, Noor Al-Saden, Constantine J Georgiou, Raymond M Reilly
Cellular dosimetry of 197Hg, 197mHg and 111In: comparison of dose deposition and identification of the cell and nuclear membrane as important targets. International journal of radiation biology (2020)